The DOI matches its Crossref record; 431 of the 431 references it cites were found in a registry or an index.
The biological pathways of Alzheimer disease: a review
Open accessAbstract
Alzheimer disease is a progressive neurodegenerative disorder, mainly affecting older people, which severely impairs patients' quality of life. In the recent years, the number of affected individuals has seen a rapid increase. It is estimated that up to 107 million subjects will be affected by 2050 worldwide. Research in this area has revealed a lot about the biological and environmental underpinnings of Alzheimer, especially its correlation with β-Amyloid and Tau related mechanics; however, the precise molecular events and biological pathways behind the disease are yet to be discovered. In this review, we focus our attention on the biological mechanics that may lie behind Alzheimer development. In particular, we briefly describe the genetic elements and discuss about specific biological processes potentially associated with the disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Items 201–400 of 431
Monoaminergic neurotransmitters, their precursors and metabolites in brains of Alzheimer patients
Storga, D., Vrecko, K., Birkmayer, J. G. D., & Reibnegger, G. (1996) · Neuroscience Letters · doi:10.1016/0304-3940(95)12256-7 · Cited by 208
CB2 receptor and amyloid pathology in frontal cortex of Alzheimer's disease patients
Solas, M., Francis, P. T., Franco, R., & Ramirez, M. J. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2012.06.005 · Cited by 207
Ramanathan, A., Nelson, A. R., Sagare, A. P., & Zlokovic, B. V. (2015) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2015.00136 · Cited by 205
Neuronal amyloid-β accumulation within cholinergic basal forebrain in ageing and Alzheimer’s disease
Baker-Nigh, A., Vahedi, S., Davis, E. G., Weintraub, S., Bigio, E. H., Klein, W. L., & Geula, C. (2015) · Brain · doi:10.1093/brain/awv024 · Cited by 205
Taylor, K. L., Henderson, A. M., & Hughes, C. C. W. (2002) · Microvascular Research · doi:10.1006/mvre.2002.2443 · Cited by 199
Miyashita, A., Koike, A., Jun, G., Wang, L.-S., Takahashi, S., Matsubara, E., Kawarabayashi, T., Shoji, M., Tomita, N., Arai, H., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0058618 · Cited by 196
Complement in the pathogenesis of Alzheimer’s disease
Morgan, B. P. (2018) · Seminars in Immunopathology · doi:10.1007/s00281-017-0662-9 · Cited by 194 · cited 1×
“It’s excessive activation exacerbates AD symptoms [157], since it influence Aβ, Tau, and APOE4 interaction in AD [158,159]”
BackgroundHippocampal RAGE immunoreactivity in early and advanced Alzheimer’s disease
Miller, M. C., Tavares, R., Johanson, C. E., Hovanesian, V., Donahue, J. E., Gonzalez, L., Silverberg, G. D., & Stopa, E. G. (2008) · Brain Research · doi:10.1016/j.brainres.2008.06.124 · Cited by 194
Coding mutations in SORL1 and Alzheimer disease
Vardarajan, B. N., Zhang, Y., Lee, J. H., Cheng, R., Bohm, C., Ghani, M., Reitz, C., Reyes‐Dumeyer, D., Shen, Y., Rogaeva, E., et al. (2015) · Annals of Neurology · doi:10.1002/ana.24305 · Cited by 191
Thomas, T., Miners, S., & Love, S. (2015) · Brain · doi:10.1093/brain/awv025 · Cited by 190
Cardiovascular Risk Factors and Incident Alzheimer Disease: A Systematic Review of the Literature
Purnell, C., Gao, S., Callahan, C. M., & Hendrie, H. C. (2009) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0b013e318187541c · Cited by 189
Bridging integrator 1 (BIN1): form, function, and Alzheimer's disease
Tan, M.-S., Yu, J.-T., & Tan, L. (2013) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2013.06.004 · Cited by 189
Jimenez, S., Torres, M., Vizuete, M., Sanchez-Varo, R., Sanchez-Mejias, E., Trujillo-Estrada, L., Carmona-Cuenca, I., Caballero, C., Ruano, D., Gutierrez, A., et al. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.209718 · Cited by 188
MFG‐E8 reverses microglial‐induced neurotoxic astrocyte (A1) via NF‐κB and PI3K‐Akt pathways
Xu, X., Zhang, A., Zhu, Y., He, W., Di, W., Fang, Y., & Shi, X. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.26918 · Cited by 188
Farlow, M. R., Salloway, S., Tariot, P. N., Yardley, J., Moline, M. L., Wang, Q., Brand-Schieber, E., Zou, H., Hsu, T., & Satlin, A. (2010) · Clinical Therapeutics · doi:10.1016/j.clinthera.2010.06.019 · Cited by 186
de la Torre, J. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-180004 · Cited by 183
Caccamo, A., De Pinto, V., Messina, A., Branca, C., & Oddo, S. (2014) · Journal of Neuroscience · doi:10.1523/jneurosci.0777-14.2014 · Cited by 182
Insights into the respiratory chain and oxidative stress
Larosa, V., & Remacle, C. (2018) · Bioscience Reports · doi:10.1042/bsr20171492 · Cited by 182
From Chronic Cerebral Hypoperfusion to Alzheimer-Like Brain Pathology and Neurodegeneration
Zhao, Y., & Gong, C.-X. (2015) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-014-0127-9 · Cited by 180
Neurotransmitter deficits in behavioural and psychological symptoms of Alzheimer's disease
Lanari, A., Amenta, F., Silvestrelli, G., Tomassoni, D., & Parnetti, L. (2006) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2005.09.016 · Cited by 180
Gibson, G. E., Blass, J. P., Beal, M. F., & Bunik, V. (2005) · Molecular Neurobiology · doi:10.1385/mn:31:1-3:043 · Cited by 179
On the Pathogenesis of Alzheimer's Disease: The MAM Hypothesis
Área-Gómez, E., & Schon, E. A. (2017) · The FASEB Journal · doi:10.1096/fj.201601309 · Cited by 178
Takata, K., Kitamura, Y., Saeki, M., Terada, M., Kagitani, S., Kitamura, R., Fujikawa, Y., Maelicke, A., Tomimoto, H., Taniguchi, T., et al. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.142356 · Cited by 176
Barnado, A., Crofford, L. J., & Oates, J. C. (2016) · Journal of Leukocyte Biology · doi:10.1189/jlb.5bt0615-234r · Cited by 176
Zou, Y., Watters, A., Cheng, N., Perry, C. E., Xu, K., Alicea, G. M., Parris, J. L. D., Baraban, E., Ray, P., Nayak, A., et al. (2019) · Cancer Discovery · doi:10.1158/2159-8290.cd-19-0270 · Cited by 176
Basak, O., Giachino, C., Fiorini, E., MacDonald, H. R., & Taylor, V. (2012) · The Journal of Neuroscience · doi:10.1523/jneurosci.0455-12.2012 · Cited by 175
NETosis in Alzheimer’s Disease
Pietronigro, E. C., Della Bianca, V., Zenaro, E., & Constantin, G. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00211 · Cited by 175
The Zinc Dyshomeostasis Hypothesis of Alzheimer's Disease
Craddock, T. J. A., Tuszynski, J. A., Chopra, D., Casey, N., Goldstein, L. E., Hameroff, S. R., & Tanzi, R. E. (2012) · PLoS ONE · doi:10.1371/journal.pone.0033552 · Cited by 174
Caccamo, A., Maldonado, M. A., Majumder, S., Medina, D. X., Holbein, W., Magrí, A., & Oddo, S. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.180638 · Cited by 173
Urbańska, M., Góźdź, A., Swiech, L. J., & Jaworski, J. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.374405 · Cited by 173
Association of MAPT haplotypes with Alzheimer’s disease risk and MAPT brain gene expression levels
Allen, M., Kachadoorian, M., Quicksall, Z., Zou, F., Chai, H. S., Younkin, C. S., Crook, J. E., Pankratz, V. S., Carrasquillo, M. M., Krishnan, S., et al. (2014) · Alzheimer s Research & Therapy · doi:10.1186/alzrt268 · Cited by 172
Hu, Y., Li, X.-C., Wang, Z.-H., Luo, Y., Zhang, X., Liu, X.-P., Feng, Q., Wang, Q., Yue, Z., Chen, Z., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.7861 · Cited by 172
Increased Dickkopf‐1 expression in transgenic mouse models of neurodegenerative disease
Rosi, M. C., Luccarini, I., Grossi, C., Fiorentini, A., Spillantini, M. G., Prisco, A., Scali, C., Gianfriddo, M., Caricasole, A., Terstappen, G. C., et al. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06566.x · Cited by 171
Highlights in BACE1 Inhibitors for Alzheimer's Disease Treatment
Coimbra, J. R. M., Marques, D. F. F., Baptista, S. J., Pereira, C. M. F., Moreira, P. I., Dinis, T. C. P., Santos, A. E., & Salvador, J. A. R. (2018) · Frontiers in Chemistry · doi:10.3389/fchem.2018.00178 · Cited by 171
Welser-Alves, J. V., & Milner, R. (2013) · Neurochemistry International · doi:10.1016/j.neuint.2013.04.007 · Cited by 169
Ryanodine receptors: physiological function and deregulation in Alzheimer disease
Prete, D. D., Checler, F., & Chami, M. (2014) · Molecular Neurodegeneration · doi:10.1186/1750-1326-9-21 · Cited by 167
Subcellular Topography of Neuronal Aβ Peptide in APPxPS1 Transgenic Mice
Langui, D., Girardot, N., El Hachimi, K. H., Allinquant, B., Blanchard, V., Pradier, L., & Duyckaerts, C. (2004) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63405-0 · Cited by 165 · cited 1×
“Noteworthy, these endosomes also contain endocytic multivesicular bodies, whose vesicles are precursors of exosomes [352,353].”
BackgroundRole of protein kinase B in Alzheimer's neurofibrillary pathology
Pei, J.-J., Khatoon, S., An, W.-L., Nordlinder, M., Tanaka, T., Braak, H., Tsujio, I., Takeda, M., Alafuzoff, I., Winblad, B., et al. (2003) · Acta Neuropathologica · doi:10.1007/s00401-002-0657-y · Cited by 165
Howard, R., McShane, R., Lindesay, J., Ritchie, C., Baldwin, A., Barber, R., Burns, A., Dening, T., Findlay, D., Holmes, C., et al. (2015) · The Lancet Neurology · doi:10.1016/s1474-4422(15)00258-6 · Cited by 165
Martin, E., Rosenthal, R. E., & Fiskum, G. (2005) · Journal of Neuroscience Research · doi:10.1002/jnr.20293 · Cited by 165
Why size matters – balancing mitochondrial dynamics in Alzheimer's disease
DuBoff, B., Feany, M., & Götz, J. (2013) · Trends in Neurosciences · doi:10.1016/j.tins.2013.03.002 · Cited by 165
Molecular Mechanisms of ER Stress and UPR in the Pathogenesis of Alzheimer’s Disease
Uddin, M. S., Tewari, D., Sharma, G., Kabir, M. T., Barreto, G. E., Bin-Jumah, M. N., Perveen, A., Abdel-Daim, M. M., & Ashraf, G. M. (2020) · Molecular Neurobiology · doi:10.1007/s12035-020-01929-y · Cited by 164
Cholinergic systems mediate action from movement to higher consciousness
Woolf, N. J., & Butcher, L. L. (2011) · Behavioural Brain Research · doi:10.1016/j.bbr.2009.12.046 · Cited by 162
Redox Mechanisms in Neurodegeneration: From Disease Outcomes to Therapeutic Opportunities
Sbodio, J. I., Snyder, S. H., & Paul, B. D. (2018) · Antioxidants and Redox Signaling · doi:10.1089/ars.2017.7321 · Cited by 160
Understanding the association of apolipoprotein E4 with Alzheimer disease: clues from its structure
Zhong, N., & Weisgraber, K. H. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.r800009200 · Cited by 159
Microglia activation states and cannabinoid system: Therapeutic implications
Mecha, M., Carrillo-Salinas, F. J., Feliú, A., Mestre, L., & Guaza, C. (2016) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2016.06.011 · Cited by 159
Ashraf, A., Clark, M., & So, P.-W. (2018) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2018.00065 · Cited by 158
Disruption of Neuronal Autophagy by Infected Microglia Results in Neurodegeneration
Alirezaei, M., Kiosses, W. B., Flynn, C. T., Brady, N. R., & Fox, H. S. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002906 · Cited by 157
Vascular Hyperpermeability and Aging
Oakley, R. P., & Tharakan, B. (2014) · Aging and Disease · doi:10.14336/ad.2014.0500114 · Cited by 156
Inhibition of p25/Cdk5 Attenuates Tauopathy in Mouse and iPSC Models of Frontotemporal Dementia
Seo, J., Kritskiy, O., Watson, L. A., Barker, S. J., Dey, D., Raja, W. K., Lin, Y.-T., Ko, T., Cho, S., Penney, J., et al. (2017) · The Journal of Neuroscience · doi:10.1523/jneurosci.0621-17.2017 · Cited by 156
Astrocyte–neuron interactions in neurological disorders
Ricci, G., Volpi, L., Pasquali, L., Petrozzi, L., & Siciliano, G. (2009) · Journal of Biological Physics · doi:10.1007/s10867-009-9157-9 · Cited by 155
Tan, L., Yu, J., Zhang, W., Wu, Z., Zhang, Q., Liu, Q., Wang, W., Wang, H.-F., Ma, X., & Cui, W. (2012) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2012.08.007 · Cited by 154
Unique insights into maternal mitochondrial inheritance in mice
Luo, S.-M., Ge, Z.-J., Wang, Z.-W., Jiang, Z.-Z., Wang, Z.-B., Ouyang, Y.-C., Hou, Y., Schatten, H., & Sun, Q.-Y. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1303231110 · Cited by 153
Lü, Y.-F., & Hawkins, R. D. (2002) · Journal of Neurophysiology · doi:10.1152/jn.2002.88.3.1270 · Cited by 153
Yan, S. D., & Stern, D. M. (2005) · International Journal of Experimental Pathology · doi:10.1111/j.0959-9673.2005.00427.x · Cited by 151
Hamilton, A., Esseltine, J. L., DeVries, R. A., Cregan, S. P., & Ferguson, S. S. G. (2014) · Molecular Brain · doi:10.1186/1756-6606-7-40 · Cited by 151
Endo‐lysosomal and autophagic dysfunction: a driving factor in Alzheimer's disease?
Whyte, L. S., Lau, A. A., Hemsley, K. M., Hopwood, J. J., & Sargeant, T. J. (2017) · Journal of Neurochemistry · doi:10.1111/jnc.13935 · Cited by 150
Targeting norepinephrine in mild cognitive impairment and Alzheimer's disease
Chalermpalanupap, T., Kinkead, B. L., Hu, W. T., Kummer, M. P., Hammerschmidt, T., Heneka, M. T., Weinshenker, D., & Levey, A. I. (2013) · Alzheimer s Research & Therapy · doi:10.1186/alzrt175 · Cited by 150
Grant, C. M., Quinn, K., & Dawes, I. W. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.4.2650 · Cited by 147
Metals and Neuronal Metal Binding Proteins Implicated in Alzheimer’s Disease
Cristóvão, J. S., Santos, R., & Gomes, C. M. (2016) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/9812178 · Cited by 146
Calcium Responses in Fibroblasts from Asymptomatic Members of Alzheimer's Disease Families
Etcheberrigaray, R., Hirashima, N., Nee, L. E., Prince, J., Govoni, S. M., Racchi, M., Tanzi, R. E., & Alkon, D. L. (1998) · Neurobiology of Disease · doi:10.1006/nbdi.1998.0176 · Cited by 144
Exosomes in Pathogenesis, Diagnosis, and Treatment of Alzheimer’s Disease
Jiang, L., Dong, H., Cao, H., Ji, X., Luan, S., & Liu, J. (2019) · Medical Science Monitor · doi:10.12659/msm.914027 · Cited by 141
The role of exosomes in the pathogenesis of Alzheimer’ disease
Xiao, T., Zhang, W., Jiao, B., Pan, C., Liu, X., & Shen, L. H. (2017) · Translational Neurodegeneration · doi:10.1186/s40035-017-0072-x · Cited by 140
Cell “Self‐Eating” (Autophagy) Mechanism in Alzheimer's Disease
Funderburk, S. F., Marcellino, B. K., & Yue, Z. (2010) · Mount Sinai Journal of Medicine: A Journal of Translational and Personalized Medicine · doi:10.1002/msj.20161 · Cited by 139
Progranulin Mutations as Risk Factors for Alzheimer Disease
Perry, D. C., Lehmann, M., Yokoyama, J. S., Karydas, A., Lee, J. J., Coppola, G., Grinberg, L. T., Geschwind, D. H., Seeley, W. W., Miller, B. L., et al. (2013) · JAMA Neurology · doi:10.1001/2013.jamaneurol.393 · Cited by 139
Alvarez, A. R., Muñoz, J. P., & Maccioni, R. B. (2001) · Experimental Cell Research · doi:10.1006/excr.2001.5152 · Cited by 138
Reichwald, J., Danner, S., Wiederhold, K., & Staufenbiel, M. (2009) · Journal of Neuroinflammation · doi:10.1186/1742-2094-6-35 · Cited by 137
Loss of canonical Wnt signaling is involved in the pathogenesis of Alzheimer’s disease.
Inestrosa, N., & Tapia-Rojas, C. (2018) · Neural Regeneration Research · doi:10.4103/1673-5374.238606 · Cited by 137
Microglial Malfunction: The Third Rail in the Development of Alzheimer's Disease
Mhatre, S. D., Tsai, C. A., Rubin, A. J., James, M. L., & Andreasson, K. I. (2015) · Trends in Neurosciences · doi:10.1016/j.tins.2015.08.006 · Cited by 134
Exosomes as Carriers of Alzheimer's Amyloid-ß
Yuyama, K., & Igarashi, Y. (2017) · Frontiers in Neuroscience · doi:10.3389/fnins.2017.00229 · Cited by 134
Ghebremedhin, E., Schultz, C., Braak, E., & Braak, H. (1998) · Experimental Neurology · doi:10.1006/exnr.1998.6860 · Cited by 133
Kim, G. W., Gasche, Y., Grzeschik, S. M., Copin, J., Maier, C. M., & Chan, P. H. (2003) · Journal of Neuroscience · doi:10.1523/jneurosci.23-25-08733.2003 · Cited by 131
Ruiz, A., Matute, C., & Alberdi, E. M. (2009) · Cell Calcium · doi:10.1016/j.ceca.2009.08.005 · Cited by 131
Endocytosis of synaptic ADAM10 in neuronal plasticity and Alzheimer’s disease
Marcello, E. E., Saraceno, C., Musardo, S., Vara, H., de la Fuente, A. G., Pelucchi, S., Marino, D. D., Borroni, B., Tramontano, A. L., Pérez‐Otaño, I., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci65401 · Cited by 130
Complement receptor 1 (CR1) and Alzheimer's disease
Crehan, H., Holton, P., Wray, S., Pocock, J., Guerreiro, R., & Hardy, J. (2012) · Immunobiology · doi:10.1016/j.imbio.2011.07.017 · Cited by 129
New Insights in the Amyloid-Beta Interaction with Mitochondria
Spuch, C., Ortolano, S., & Fernández-Balbuena, C. N. (2012) · Journal of Aging Research · doi:10.1155/2012/324968 · Cited by 128
Recommendations of the Alzheimer's Disease–Related Dementias Conference
Montine, T. J., Koroshetz, W. J., Babcock, D., Dickson, D. W., Galpern, W. R., Glymour, M. M., Greenberg, S. M., Hutton, M. L., Knopman, D. S., Kuzmichev, A. N., et al. (2014) · Neurology · doi:10.1212/wnl.0000000000000733 · Cited by 128
Reactivity of Apolipoprotein E4 and Amyloid β Peptide
Ji, Z.-S., Müllendorff, K., Cheng, I. H., Miranda, R. D., Huang, Y., & Mahley, R. W. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m506646200 · Cited by 127
The Role of SORL1 in Alzheimer’s Disease
Yin, R.-H., Yu, J.-T., & Tan, L. (2015) · Molecular Neurobiology · doi:10.1007/s12035-014-8742-5 · Cited by 126
Farrer, L. A. (1997) · JAMA · doi:10.1001/jama.1997.03550160069041 · Cited by 124
Relationships between Mitochondrial Dysfunction and Neurotransmission Failure in Alzheimer’s Disease
Wong, K. Y., Roy, J., Fung, M., Heng, B. C., Zhang, C., & Lim, L. W. (2020) · Aging and Disease · doi:10.14336/ad.2019.1125 · Cited by 124
Liguori, C., Chiaravalloti, A., Sancesario, G., Stefani, A., Sancesario, G. M., Mercuri, N. B., Schillaci, O., & Pierantozzi, M. (2016) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-016-3417-2 · Cited by 123
In vivo imaging of synaptic loss in Alzheimer’s disease with [18F]UCB-H positron emission tomography
Bastin, C., Bahri, M. A., Meyer, F., Manard, M., Delhaye, E., Plenevaux, A., Becker, G., Seret, A., Mella, C., Giacomelli, F., et al. (2019) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-019-04461-x · Cited by 123
Cerebrospinal Fluid Biomarkers of Neurovascular Dysfunction in Mild Dementia and Alzheimer'S Disease
Sweeney, M. D., Sagare, A. P., & Zlokovic, B. V. (2015) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2015.76 · Cited by 122
Determinants of neuronal vulnerability in neurodegenerative diseases
Morrison, B. M., Hof, P. R., & Morrison, J. H. (1998) · Annals of Neurology · doi:10.1002/ana.410440706 · Cited by 120
Molecular Mechanisms of Metal Toxicity in the Pathogenesis of Alzheimer’s Disease
Kabir, M. T., Uddin, M. S., Zaman, S., Begum, Y., Ashraf, G. M., Bin-Jumah, M. N., BUNGAU, S. G., Mousa, S. A., & Abdel‐Daim, M. M. (2020) · Molecular Neurobiology · doi:10.1007/s12035-020-02096-w · Cited by 119
Metal Binding Dictates Conformation and Function of the Amyloid Precursor Protein (APP) E2 Domain
Dahms, S. O., Könnig, I., Roeser, D., Gührs, K., Mayer, M., Kaden, D., Multhaup, G., & Than, M. E. (2012) · Journal of Molecular Biology · doi:10.1016/j.jmb.2011.12.057 · Cited by 118
Jiang, T., Yu, J., Hu, N., Tan, M., Zhu, X., & Tan, L. (2013) · Molecular Neurobiology · doi:10.1007/s12035-013-8536-1 · Cited by 117
Potential Contribution of Exosomes to the Prion-Like Propagation of Lesions in Alzheimer’s Disease
Vingtdeux, V., Sergeant, N., & Buée, L. (2012) · Frontiers in Physiology · doi:10.3389/fphys.2012.00229 · Cited by 116
The Cell Biology of the Unfolded Protein Response
Diehl, J. A., Fuchs, S. Y., & Koumenis, C. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.05.018 · Cited by 115
Feldman, H., Gauthier, S. G., Hecker, J. R., Vellas, B. J., Xu, Y., Ieni, J. R., & Schwam, E. M. (2005) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.1325 · Cited by 114
Autophagy and oxidative stress in non-communicable diseases: A matter of the inflammatory state?
Peña‐Oyarzún, D., Bravo, R., Díaz‐Vegas, A., Aleman, L., Chiong, M., García, L., Claudia Bambs, S., Troncoso, R., Cifuentes, M., Morselli, E., et al. (2018) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2018.05.084 · Cited by 114
Copper Promotes the Trafficking of the Amyloid Precursor Protein
Acevedo, K. M., Hung, Y. H., Dalziel, A. H., Li, Q., Laughton, K. M., Wikhe, K., Rembach, A., Roberts, B. R., Masters, C. L., Bush, A. I., et al. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.128512 · Cited by 113
Dysregulation of Intracellular Calcium Signaling in Alzheimer's Disease
Александровна, П. Е., Pchitskaya, E. I., & Борисович, Б. И. (2018) · Antioxidants and Redox Signaling · doi:10.1089/ars.2018.7506 · Cited by 113
Salminen, A., Haapasalo, A., Kauppinen, A., Kaarniranta, K., Soininen, H. S., & Hiltunen, M. O. (2015) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2015.05.001 · Cited by 112
A role for APP in Wnt signalling links synapse loss with β-amyloid production
Elliott, C., Rojo, A. I., Ribé, E. M., Broadstock, M., Xia, W., Morin, P., Semënov, M. V., Baillie, G. S., Cuadrado, A., Al‐Shawi, R., et al. (2018) · Translational Psychiatry · doi:10.1038/s41398-018-0231-6 · Cited by 112
An Integrated View on Vascular Dysfunction in Alzheimer’s Disease
Klohs, J. (2019) · Neurodegenerative Diseases · doi:10.1159/000505625 · Cited by 111 · cited 2×
“These events are detrimental for the normal cerebral function that would result in disturbed homeostasis, but also in blood-brain barrier (BBB) damage and micro-fractures in cerebral vases [235],”
BackgroundLong, J., Liu, C., Sun, L., Gao, H., & Liu, J. (2008) · Neurochemical Research · doi:10.1007/s11064-008-9882-7 · Cited by 110
Redox Signaling in Neurotransmission and Cognition During Aging
Kumar, A., Yegla, B., & Foster, T. C. (2017) · Antioxidants and Redox Signaling · doi:10.1089/ars.2017.7111 · Cited by 109
Farías, G. G., Vallés, A. S., Colombres, M., Godoy, J. A., Toledo, E. M., Lukas, R. J., Barrantes, F. J., & Inestrosa, N. C. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.3934-06.2007 · Cited by 108
Inhibition of Bax protects neuronal cells from oligomeric Aβ neurotoxicity
Kudo, W., Hp, L., Smith, M. A., Zhu, X., Matsuyama, S., & Lee, H.-G. (2012) · Cell Death and Disease · doi:10.1038/cddis.2012.43 · Cited by 107
Brain Derived Exosomes Are a Double-Edged Sword in Alzheimer’s Disease
Song, Z., Xu, Y., Deng, W., Zhang, L., Zhu, H., Yü, P., Qu, Y., Zhao, W., Han, Y., & Qin, C. (2020) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2020.00079 · Cited by 106
Microglial mitophagy mitigates neuroinflammation in Alzheimer's disease
Lautrup, S., Lou, G., Aman, Y., Nilsen, H., Tao, J., & Fang, E. F. (2019) · Neurochemistry International · doi:10.1016/j.neuint.2019.104469 · Cited by 105
Interplay Between Mitochondrial Oxidative Disorders and Proteostasis in Alzheimer’s Disease
Llanos-González, E., Henares-Chavarino, Á. A., Pedrero-Prieto, C. M., García‐Carpintero, S., Frontiñán-Rubio, J., Sancho-Bielsa, F. J., Alcain, F. J., Peinado, J. R., Rabanal‐Ruiz, Y., & Durán‐Prado, M. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.01444 · Cited by 104
Ojala, J. O., Sutinen, E. M., Salminen, A., & Pirttilä, T. (2008) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2008.09.012 · Cited by 102
C9orf72 Hexanucleotide Repeat Expansions in Clinical Alzheimer Disease
Harms, M., Benitez, B. A., Cairns, N., Cooper, B., Cooper, P., Mayo, K., Carrell, D., Faber, K., Williamson, J., Bird, T., et al. (2013) · JAMA Neurology · doi:10.1001/2013.jamaneurol.537 · Cited by 102
Belinson, H., Lev, D., Masliah, E., & Michaelson, D. M. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.5633-07.2008 · Cited by 101 · cited 1×
“For example, Apolipoprotein E4 (apoE4) overexpression potentially causes an Aβ accumulation in lysosomes, leading to neuronal death in the hippocampus [299,300].”
BackgroundHullinger, R., O’Riordan, K. J., & Bürger, C. (2015) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2015.08.006 · Cited by 100
Gerber, H., Wu, F., Dimitrov, M. I., Osuna, G. M. G., & Fraering, P. C. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.754101 · Cited by 100
PICALM Gene rs3851179 Polymorphism Contributes to Alzheimer’s Disease in an Asian Population
Liu, G., Zhang, S., Cai, Z., Ma, G., Zhang, L., Jiang, Y., Feng, R., Liao, M., Chen, Z., Zhao, B., et al. (2013) · NeuroMolecular Medicine · doi:10.1007/s12017-013-8225-2 · Cited by 98
Cognitive impairment in humanized APP×PS1 mice is linked to Aβ1–42 and NOX activation
Bruce-Keller, A. J., Gupta, S., Knight, A. G., Beckett, T. L., McMullen, J. M., Davis, P. R., Murphy, M. P., Van Eldik, L. J., St Clair, D., & Keller, J. N. (2011) · Neurobiology of Disease · doi:10.1016/j.nbd.2011.07.012 · Cited by 96 · cited 1×
“The increased OS state in turn triggers several molecular events that are strictly linked with AD symptomatology development [197].”
BackgroundPromoting Autophagic Clearance: Viable Therapeutic Targets in Alzheimer's Disease
Friedman, L. G., Qureshi, Y. H., & Yu, W. H. (2014) · Neurotherapeutics · doi:10.1007/s13311-014-0320-z · Cited by 96
Royston, M. C., Mann, D. M. A., Pickering-Brown, S. M., Owen, F., Perry, R., Raghavan, R., Khin-IMu, C., Tyrer, S. P., Day, K. A., Crook, R., et al. (1994) · Neuroreport · doi:10.1097/00001756-199412000-00044 · Cited by 94
García‐Casares, N., Jorge, R. E., García-Arnés, J. A., Ación, L., Berthier, M. L., Gonzalez-Alegre, P., Nabrozidis, A., Gutiérrez, A., Ariza, M. J., Rioja, J., et al. (2014) · Journal of Alzheimer s Disease · doi:10.3233/jad-140702 · Cited by 90
Endocytic disturbances distinguish among subtypes of alzheimer's disease and related disorders
Cataldo, A., Rebeck, G. W., Ghetti, B., Hulette, C., Lippa, C., Van Broeckhoven, C., Van Duijn, C., Cras, P., Bogdanovic, N., Bird, T., et al. (2001) · Annals of Neurology · doi:10.1002/ana.1254 · Cited by 90
Potential Neuroprotective Effects of Adiponectin in Alzheimer’s Disease
Ng, R. C.-L., & Chan, K. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18030592 · Cited by 87
Maternal transmission of Alzheimer's disease: prodromal metabolic phenotype and the search for genes
Mosconi, L., Berti, V., Swerdlow, R. H., Pupi, A., Duara, R., & de Leon, M. (2010) · Human Genomics · doi:10.1186/1479-7364-4-3-170 · Cited by 85 · cited 2×
“A trend of inheritance do exist in AD cases: children of female AD subjects are at higher risk for developing AD than children of male AD subjects [357].”
BackgroundRheb and mTOR Regulate Neuronal Polarity through Rap1B
Li, Y., Werner, H., & Püschel, A. W. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m802431200 · Cited by 83
Morales‐Corraliza, J., Wong, H., Mazzella, M. J., Che, S., Lee, S. H., Petkova, E., Wagner, J. D., Hemby, S. E., Ginsberg, S. D., & Mathews, P. M. (2016) · Journal of Neuroscience · doi:10.1523/jneurosci.4640-14.2016 · Cited by 83
Blood pressure decrease correlates with tau pathology and memory decline in hypertensive elderly
Glodzik, L., Rusinek, H., Pirraglia, E., McHugh, P. F., Tsui, W., Williams, S., Cummings, M., Li, Y., Rich, K. E., Randall, C., et al. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.06.011 · Cited by 82
Nakajima, K., Tohyama, Y., Maeda, S., Kohsaka, S., & Kurihara, T. (2007) · Neurochemistry International · doi:10.1016/j.neuint.2007.02.006 · Cited by 81
Calcium, Reactive Oxygen Species, and Synaptic Plasticity
Hidalgo, C., & Arias‐Cavieres, A. (2016) · Physiology · doi:10.1152/physiol.00038.2015 · Cited by 81
Kawahara, M., Kato-Negishi, M., & Tanaka, K. (2017) · Metallomics · doi:10.1039/c7mt00046d · Cited by 80 · cited 5×
“In particular, it was observed that the amyloidogenic protein and its precursors have the ability to bind metals [130].”
BackgroundInfluentialIsopi, E., Granzotto, A., Corona, C., Bomba, M., Ciavardelli, D., Curcio, M., Canzoniero, L. M. T., Navarra, R., Lattanzio, R., Piantelli, M., et al. (2014) · Neurobiology of Disease · doi:10.1016/j.nbd.2014.11.013 · Cited by 80
Association of GWAS Top Hits With Late-onset Alzheimer Disease in Korean Population
Chung, S. J., Lee, J., Kim, S. Y., You, S., Kim, M. J., Lee, J., & Koh, J. (2012) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0b013e31826d7281 · Cited by 79
The relationship between complement factor C3, APOE ε4, amyloid and tau in Alzheimer’s disease
Initiative, A. D. N., Bonham, L. W., Desikan, R. S., & Yokoyama, J. S. (2016) · Acta Neuropathologica Communications · doi:10.1186/s40478-016-0339-y · Cited by 79
Brickell, K. L., Steinbart, E. J., Rumbaugh, M., Payami, H., Schellenberg, G. D., Van Deerlin, V., Yuan, W., & Bird, T. D. (2006) · Archives of Neurology · doi:10.1001/archneur.63.9.1307 · Cited by 77 · cited 2×
“Around 13% of these subjects present an autosomal dominant inheritance with at least 3 generations affected [42].”
BackgroundGenetics of PICALM Expression and Alzheimer's Disease
Parikh, I. J., Fardo, D. W., & Estus, S. (2014) · PLoS ONE · doi:10.1371/journal.pone.0091242 · Cited by 77
Viral Hypothesis and Antiviral Treatment in Alzheimer’s Disease
Devanand, D. P. (2018) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-018-0863-1 · Cited by 77
Quintanilla, R. A., Orellana, J. A., & Rommy von Bernhardi, M. (2012) · Archives of Medical Research · doi:10.1016/j.arcmed.2012.10.016 · Cited by 76
Immune System in the Brain: A Modulatory Role on Dendritic Spine Morphophysiology?
Bitzer-Quintero, O. K., & González‐Burgos, I. (2012) · Neural Plasticity · doi:10.1155/2012/348642 · Cited by 75
Morris, G., Walder, K. R., Puri, B. K., Berk, M., & Maes, M. H. J. (2015) · Molecular Neurobiology · doi:10.1007/s12035-015-9392-y · Cited by 74
Synthesis and Biological Evaluation of New Cholinesterase Inhibitors for Alzheimer’s Disease
Hussein, W., Sağlık, B. N., Levent, S., Korkut, B., Ilgın, S., Özkay, Y., & Kaplancıklı, Z. A. (2018) · Molecules · doi:10.3390/molecules23082033 · Cited by 74
The role of glial cells in Alzheimer disease: potential therapeutic implications
Cabezas, I. L., Batista, A. H., & Rol, G. P. (2014) · Neurología (English Edition) · doi:10.1016/j.nrleng.2012.10.009 · Cited by 73
Carden, T., Singh, B. P., Mooga, V. P., Bajpai, P., & Singh, K. K. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m117.797001 · Cited by 73
Control of Vascular Cell Differentiation by Homeobox Transcription Factors
Gorski, D. H., & Walsh, K. (2003) · Trends in Cardiovascular Medicine · doi:10.1016/s1050-1738(03)00081-1 · Cited by 72
Notch1 hallmarks fibrillary depositions in sporadic Alzheimer’s disease
Brai, E., Raio, N. A., & Alberi, L. A. (2016) · Acta Neuropathologica Communications · doi:10.1186/s40478-016-0327-2 · Cited by 72
The Role of Interleukin-18, Oxidative Stress and Metabolic Syndrome in Alzheimer’s Disease
Ojala, J. O., & Sutinen, E. M. (2017) · Journal of Clinical Medicine · doi:10.3390/jcm6050055 · Cited by 72
Mengel‐From, J., Christensen, K., McGue, M. K., & Christiansen, L. (2010) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2010.07.016 · Cited by 71
Schiera, G., Di Liegro, C. M., & Di Liegro, I. (2015) · BioMed Research International · doi:10.1155/2015/152926 · Cited by 70
Dynamic action of neurometals at the synapse
Tamano, H., & Takeda, A. (2011) · Metallomics · doi:10.1039/c1mt00008j · Cited by 70
Age‐dependent effects of APOE ε4 in preclinical Alzheimer's disease
Bonham, L. W., Geier, E. G., Fan, C. C., Leong, J. K., Besser, L. M., Kukull, W. A., Kornak, J., Andreassen, O. A., Schellenberg, G. D., Rosen, H. J., et al. (2016) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.333 · Cited by 70
Arias-Cavieres, A., Adasme, T., Sánchez, G., Muñoz, P., & Hidalgo, C. (2017) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2017.00111 · Cited by 70
Azevedo, E. P., Ledo, J. H., Barbosa, G., Sobrinho, M., Diniz, L. P., da Fonseca, A. C. C., Gomes, F. C. A., Romão, L. F., Lima, F. R. S., Palhano, F. L., et al. (2013) · Cell Death and Disease · doi:10.1038/cddis.2013.325 · Cited by 69
Redox Biology in Neurological Function, Dysfunction, and Aging
Franco, R., & Vargas, M. R. (2018) · Antioxidants & Redox Signaling · doi:10.1089/ars.2018.7509 · Cited by 68
Insulin-signaling Pathway Regulates the Degradation of Amyloid β-protein via Astrocytes
Yamamoto, N., Ishikuro, R., Tanida, M., Suzuki, K., Ikeda‐Matsuo, Y., & Sobue, K. (2018) · Neuroscience · doi:10.1016/j.neuroscience.2018.06.018 · Cited by 68
Mitochondria: The Common Upstream Driver of Amyloid-β and Tau Pathology in Alzheimers Disease
Silva, D. F., Esteves, A. R., Oliveira, C. R., & Cardoso, S. M. (2011) · Current Alzheimer Research · doi:10.2174/156720511796391872 · Cited by 67
ATP5H/KCTD2 locus is associated with Alzheimer's disease risk
Initiative, A. D. N., Boada, M., Antúnez, C., Ramírez‐Lorca, R., DeStefano, A. L., González‐Pérez, A., Gayán, J., López‐Arrieta, J., Ikram, M. A., Hernández, I., et al. (2013) · Molecular Psychiatry · doi:10.1038/mp.2013.86 · Cited by 66
SanMartín, C. D., Veloso, P., Adasme, T., Lobos, P., Bruna, B., Galaz, J., García, A., Härtel, S., Hidalgo, C., & Paula-Lima, A. C. (2017) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2017.00115 · Cited by 66
McColl, B. W., Rose, N., Robson, F. H., Rothwell, N. J., & Lawrence, C. B. (2009) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2009.217 · Cited by 65
Potential of GPCRs to modulate MAPK and mTOR pathways in Alzheimer’s disease
Franco, R., Martínez‐Pinilla, E., Navarro, G., & Zamarbide, M. (2017) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2017.01.004 · Cited by 65
Borroto‐Escuela, D. O., Tarakanov, A. O., Guidolin, D., Ciruela, F., Agnati, L. F., & Fuxé, K. (2011) · IUBMB Life · doi:10.1002/iub.473 · Cited by 63
A genome-wide study reveals rare CNVs exclusive to extreme phenotypes of Alzheimer disease
Investigators of the GMAJ project, Rovelet‐Lecrux, A., Legallic, S., Wallon, D., Flaman, J., Martinaud, O., Bombois, S., Rollin‐Sillaire, A., Michon, A., Ber, I. L., et al. (2011) · European Journal of Human Genetics · doi:10.1038/ejhg.2011.225 · Cited by 62
Use of diuretics is associated with reduced risk of Alzheimer's disease: the Cache County Study
Chuang, Y., Breitner, J. C. S., Chiu, Y., Khachaturian, A. S., Hayden, K. M., Corcoran, C., Tschanz, J. T., Norton, M. C., Munger, R., Welsh-Bohmer, K. A., et al. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.05.002 · Cited by 61
Role of GPCR signaling and calcium dysregulation in Alzheimer's disease
Sushma, & Mondal, A. C. (2019) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2019.103414 · Cited by 61
Accumulation of overoxidized Peroxiredoxin III in aged rat liver mitochondria
Musicco, C., Capelli, V., Pesce, V., Timperio, A. M., Calvani, M., Mosconi, L., Zolla, L., Cantatore, P., & Gadaleta, M. N. (2009) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2009.03.002 · Cited by 60
Targeting Insulin Signaling for the Treatment of Alzheimer's Disease
Chen, Y., Zhang, J., Zhang, B., & Gong, C. (2015) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026615666150813142423 · Cited by 59
The prevalence of CD33 and MS4A6A variant in Chinese Han population with Alzheimer’s disease
Deng, Y., Liu, L., Wang, Y., Tang, H., Ren, R., Xu, W. L., Ma, J., Wang, L., Zhuang, J.-P., Wang, G., et al. (2012) · Human Genetics · doi:10.1007/s00439-012-1154-6 · Cited by 59
Redox state regulates HIF-1α and its DNA binding and phosphorylation in salmonid cells
Nikinmaa, M., Kangasjärvi, S., & Soitamo, A. J. (2004) · Journal of Cell Science · doi:10.1242/jcs.01192 · Cited by 59
Ashby, E. L., & Kehoe, P. G. (2013) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2013.812631 · Cited by 58
Papel de la glía en la enfermedad de Alzheimer. Futuras implicaciones terapéuticas
Cabezas, I. L., Batista, A. H., & Rol, G. P. (2012) · Neurología · doi:10.1016/j.nrl.2012.10.006 · Cited by 58
Liu, G., Wang, H., Liu, J., Li, J., Li, H., Ma, G., Jiang, Y., Chen, Z., Zhao, B., & Li, K. (2013) · NeuroMolecular Medicine · doi:10.1007/s12017-013-8250-1 · Cited by 58
Campos-Peña, V., Toral-Rios, D., Becerril-Pérez, F., Sánchez-Torres, C., Delgado-Namorado, Y., Torres-Ossorio, E., Franco-Bocanegra, D., & Carvajal, K. (2017) · Antioxidants & Redox Signaling · doi:10.1089/ars.2016.6768 · Cited by 58
Serotonin 2A (5-HT2A) Receptor Function: Ligand-Dependent Mechanisms and Pathways
Chattopadhyay, A. (2007) · CRC Press eBooks · doi:10.1201/9781420005752-11 · Cited by 56
Bracco, L., Bessi, V., Padiglioni, S., Marini, S., & Pepeu, G. (2014) · Journal of Alzheimer s Disease · doi:10.3233/jad-131154 · Cited by 55
Campanucci, V. A., Krishnaswamy, A., & Cooper, E. (2008) · Journal of Neuroscience · doi:10.1523/jneurosci.5130-07.2008 · Cited by 55
The contribution of astrocytes to Alzheimer's disease
Birch, A. M. (2014) · Biochemical Society Transactions · doi:10.1042/bst20140171 · Cited by 54
Huang, K., Lin, K., Ho, M.-Y., Chang, Y.-J., Chang, C.-H., Wey, S., Hsieh, C., Yen, T., Hsiao, I., & Lee, T. (2012) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2012.04.014 · Cited by 54
Nitric oxide‐mediated regulation of ‐amyloid clearance via alterations of MMP‐9/TIMP‐1
Ridnour, L. A., Dhanapal, S., Hoos, M., Wilson, J., Lee, J., Cheng, R. Y. S., Brueggemann, E. E., Hines, H. B., Wilcock, D. M., Vitek, M. P., et al. (2012) · Journal of Neurochemistry · doi:10.1111/jnc.12028 · Cited by 54
The Mitochondrial DNA Polymerase Promotes Elimination of Paternal Mitochondrial Genomes
Yu, Z., O’Farrell, P. H., Yakubovich, N., & DeLuca, S. Z. (2017) · Current Biology · doi:10.1016/j.cub.2017.02.014 · Cited by 53
Altered expression of Notch1 in Alzheimer's disease
Cho, S.-J., Yun, S., Jo, C., Jeong, J., Park, M. H., Han, C., & Koh, Y. H. (2019) · PLoS ONE · doi:10.1371/journal.pone.0224941 · Cited by 53
Lack of Pannexin 1 Alters Synaptic GluN2 Subunit Composition and Spatial Reversal Learning in Mice
Gajardo, I., Salazar, C., López-Espíndola, D., Estay, C., Flores‐Muñoz, C., Elgueta, C., González‐Jamett, A. M., Martínez, A. D., Muñoz, P., & Ardiles, Á. O. (2018) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2018.00114 · Cited by 52
Miller, V. M., Lawrence, D. A., Mondal, T. K., & Seegal, R. F. (2009) · Brain Research · doi:10.1016/j.brainres.2009.04.029 · Cited by 48
Karakuzu, A., Appelhoff, S., Auer, T., Boudreau, M., Feingold, F. W., KHAN, A. R., Lazari, A., Markiewicz, C. J., Mulder, M., Phillips, C. L. M., et al. (2022) · Scientific Data · doi:10.1038/s41597-022-01571-4 · Cited by 48
Aβ generation in autophagic vacuoles
Mizushima, N. (2005) · The Journal of Cell Biology · doi:10.1083/jcb.200508097 · Cited by 46
Anderson, N. J., King, M. R., Delbruck, L., & Jolivalt, C. G. (2014) · Disease Models & Mechanisms · doi:10.1242/dmm.015750 · Cited by 46
BIN1 gene rs744373 polymorphism contributes to Alzheimer's disease in East Asian population
Liu, G., Zhang, S., Cai, Z., Li, Y., Cui, L., Ma, G., Jiang, Y., Zhang, L., Feng, R., Liao, M., et al. (2013) · Neuroscience Letters · doi:10.1016/j.neulet.2013.02.075 · Cited by 45
The genetic contributions of SNCA and LRRK2 genes to Lewy Body pathology in Alzheimer's disease
Linnertz, C. L., Lutz, M. W., Ervin, J. F., Allen, J., Miller, N. R., Welsh-Bohmer, K. A., Roses, A. D., & Chiba‐Falek, O. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddu196 · Cited by 44
Illiteracy and the incidence of Alzheimer's disease in the Yonchon County survey, Korea
Lee, J., Chang, S. M., Jang, H.-S., Chang, J. S., Suh, G., Jung, H., Jeon, H.-J., & Cho, M. J. (2008) · International Psychogeriatrics · doi:10.1017/s1041610208007333 · Cited by 44
Zhao, Q., Yu, J., Tan, M., & Tan, L. (2014) · Molecular Neurobiology · doi:10.1007/s12035-014-8759-9 · Cited by 43
Neurotransmitter changes in early- and late-onset alzheimer-type dementia
Heii, A., Ichimiya, Y., Kenji, K., Takashi, M., & Iizuka, R. (1992) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/0278-5846(92)90106-o · Cited by 42
Qi, Y., Klyubin, I. V., Harney, S. C., Hu, N., Cullen, W. K., Grant, M. K. O., Steffen, J., Wilson, E. N., Carmo, S. D., Remy, S., et al. (2014) · Acta Neuropathologica Communications · doi:10.1186/s40478-014-0175-x · Cited by 41
Popović, M., Laumonnier, Y., Burýšek, L., Syrovets, T., & Simmet, T. (2008) · Journal of Leukocyte Biology · doi:10.1189/jlb.0907652 · Cited by 40
Fernández‐Fernández, D., Rosenbrock, H., & Kroker, K. S. (2015) · Synapse · doi:10.1002/syn.21840 · Cited by 39
Jin, C., Li, W., Yuan, J., Xu, W., & Cheng, Z. (2012) · Neuroscience Letters · doi:10.1016/j.neulet.2012.08.032 · Cited by 39
Lo, A. C., Iscru, E., Blum, D. L., Tesseur, I. C., Callaerts‐Vegh, Z., Buée, L., Strooper, B. D., Balschun, D., & D’Hooge, R. (2013) · Journal of Alzheimer s Disease · doi:10.3233/jad-122296 · Cited by 39
TREM2 variants and risk of Alzheimer’s disease: a meta-analysis
Lu, Y., Liu, W., & Wang, X. (2015) · Neurological Sciences · doi:10.1007/s10072-015-2274-2 · Cited by 37
Genetic variation in Clusterin gene and Alzheimer's disease risk in Han Chinese
Yu, J., Ma, X., Wang, Y., Sun, L., Tan, L., Hu, N., & Tan, L. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.01.010 · Cited by 37
Han, X., Yang, L., Du, H., Sun, Q., Wang, X., Cong, L., Liu, X., Yin, L., Li, S., & Du, Y. (2015) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-015-0268-5 · Cited by 37
Flores‐Muñoz, C., Gómez, B., Mery, E., Mujica, P., Gajardo, I., Córdova, C., López-Espíndola, D., Duran-Aniotz, C. A., Hetz, C. A., Muñoz, P., et al. (2020) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2020.00046 · Cited by 37
Distribution of neurons of origin of zinc-containing projections in the amygdala of the rat
Christensen, M.-K., & Geneser, F. A. (1995) · Anatomy and Embryology · doi:10.1007/bf00187821 · Cited by 36
Molinuevo, J. L., Berthier, M. L., & Rami, L. (2009) · Archives of Gerontology and Geriatrics · doi:10.1016/j.archger.2009.11.004 · Cited by 36
Genes involved in Alzheimer's disease, a survey of possible candidates
Serretti, A., Artioli, P., Quartesan, R., & Ronchi, D. D. (2005) · Journal of Alzheimer s Disease · doi:10.3233/jad-2005-7410 · Cited by 35
Zhang, N., Wei, C., Du, H.-J., Shi, F., & Cheng, Y. (2015) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000430808 · Cited by 35
Vascular Plasticity and Cognition During Normal Aging and Dementia
Montagne, A., Pa, J., & Zloković, B. V. (2015) · JAMA Neurology · doi:10.1001/jamaneurol.2014.4636 · Cited by 35
Yoon, K., Lee, H., Jo, Y. S., An, K., Jung, S., Jeong, M.-W., Kwon, S., Kim, N.-S., Jeong, H., Ahn, S.-H., et al. (2012) · Molecular Brain · doi:10.1186/1756-6606-5-40 · Cited by 35
SNCA Gene Polymorphism may Contribute to an Increased Risk of Alzheimer's Disease
Wang, Q., Tian, Q., Song, X., Liu, Y., & Li, W. (2016) · Journal of Clinical Laboratory Analysis · doi:10.1002/jcla.21986 · Cited by 35
Solé, M., Esteban-López, M., Taltavull, B., Fábregas, C., Fadó, R., Casals, N., Rodríguez-Álvarez, J., Miñano-Molina, A. J., & Unzeta, M. (2019) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2019.04.016 · Cited by 35
Chen, Y., Yu, X.-Y., Chen, L., Vaziri, N. D., Ma, S., & Zhao, Y. (2019) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2019.06.012 · Cited by 35
Sutinen, E. M., Korolainen, M. A., Häyrinen, J., Alafuzoff, I., Petratos, S., Salminen, A., Soininen, H., Pirttilä, T., & Ojala, J. O. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00214 · Cited by 34
Cited by
Hill, M. A., & Gammie, S. C. (2022) · Scientific Reports · doi:10.1038/s41598-022-22179-z · Cited by 56
Stanciu, G. D., Rusu, R. N., Bild, V., Filipiuc, L. E., Tamba, B.-I., & Ababei, D. C. (2021) · Biomedicines · doi:10.3390/biomedicines9050576 · Cited by 47
Masitinib for the Treatment of Alzheimer’s Disease
Ettcheto, M., Cano, A., Sanchez-López, E., Verdaguer, E., Folch, J., Auladell, C., & Camins, A. (2021) · Neurodegenerative Disease Management · doi:10.2217/nmt-2021-0019 · Cited by 28
Fibrin-targeting immunotherapy for dementia
Kantor, A. B., Akassoglou, K., & Stavenhagen, J. B. (2023) · The Journal of Prevention of Alzheimer's Disease · doi:10.14283/jpad.2023.105 · Cited by 24
Alzheimer’s disease: from early pathogenesis to novel therapeutic approaches
Prajapati, S. K., Pathak, A., & Samaiya, P. K. (2024) · Metabolic Brain Disease · doi:10.1007/s11011-024-01389-6 · Cited by 21
Metadata
- Authors
- Calabrò, M., Department of Biomedical and Dental Sciences and Morphofunctional Imaging, U. O. M., Rinaldi, C., Santoro, G., & Crisafulli, C.
- Venue
- AIMS Neuroscience
- Published
- 2021
- Volume
- 8
- Issue
- 1
- Pages
- 86-132
- ISSN
- 2373-7972 (ISSN-L)
- OpenAlex
- W3112246556
- Cited by
- 265
- References
- 431
- FWCI
- 14.83
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.